Sagimet Biosciences Inc.
NASDAQ:SGMT · NASDAQ Global Market
+$0.09 today
Vol 2.63M · Avg 1.49M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-20.10%
Period High
$10.24
Period Low
$4.55
Latest
$6.68
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Achieve Life Sciences, Inc.
NASDAQ:ACHV
$503.49M
Assembly Biosciences, Inc.
NASDAQ:ASMB
$386.36M
Atea Pharmaceuticals, Inc.
NASDAQ:AVIR
$347.72M
Entrada Therapeutics, Inc.
NASDAQ:TRDA
$267.28M
Foghorn Therapeutics Inc.
NASDAQ:FHTX
$243.66M
Zura Bio Limited
NASDAQ:ZURA
$238.63M
Voyager Therapeutics, Inc.
NASDAQ:VYGR
$223.98M
Arcturus Therapeutics Holdings Inc.
NASDAQ:ARCT
$212.89M
Immuneering Corporation
NASDAQ:IMRX
$157.78M
Humacyte, Inc.
NASDAQ:HUMA
$157.21M
What is the latest SGMT filing?
The latest filing shown is 4 dated Jun 15, 2026.
How many recent filings does SGMT have?
Intrinsic Alpha currently shows 20 recent filings for SGMT.
Explore More
Continue the stock analysis
Jump to another research area for this company.